Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase

International Immunology

Volumn 22, Issue 6, 2010, Pages 433-442

  Stroo, Ingrid ^a   Stokman, Geurt ^a   Teske, Gwen J D ^a   Raven, Anje ^a   Butter, Loes M ^a   Florquin, Sandrine ^a   Leemans, Jaklien C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chemokine; I R; Kidney; Microarray

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CX3CR1; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CHEMOKINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; LEUKOCYTE AGGREGATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; TISSUE REPAIR; ANIMAL; C57BL MOUSE; CELL COUNT; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; KIDNEY; MACROPHAGE; METABOLISM; NEUTROPHIL; PATHOLOGY; REPERFUSION INJURY; SURGERY; T LYMPHOCYTE;

ANIMALS; CELL COUNT; CHEMOKINES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOCHEMISTRY; INFLAMMATION; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; NEUTROPHILS; RECEPTORS, CHEMOKINE; REPERFUSION INJURY; T-LYMPHOCYTES;

EID: 77954012344     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq025     Document Type: Article

References (48)

1. Agrawal, M. and Swartz, R. 2000. Acute renal failure. Am. Fam. Physician. 61:2077.
2. Preston, R. A. and Epstein, M. 1997. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J. Hypertens. 15:1365.
3. Charo, I. F. and Ransohoff, R. M. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354:610.
4. Le, Y., Zhou, Y., Iribarren, P. and Wang, J. 2004. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol. Immunol. 1:95.
5. Pelus, L. M. and Fukuda, S. 2008. Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia 22:466.
6. Scapini, P., Lapinet-Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F. and Cassatella, M. A. 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177:195.
7. Yang, L. and Mosmann, T. 2004. Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions. Eur. J. Immunol. 34:1617.
8. Ciesielski, C. J., Andreakos, E., Foxwell, B. M. and Feldmann, M. 2002. TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretion. Eur. J. Immunol. 32:2037.
9. Segerer, S., Nelson, P. J. and Schlondorff, D. 2000. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J. Am. Soc. Nephrol. 11:152.
10. Anders, H. J., Vielhauer, V. and Schlondorff, D. 2003. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 63:401.
11. Zoja, C., Corna, D., Benedetti, G. et al. 1998. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney Int. 53:726.
12. Hasegawa, H., Kohno, M., Sasaki, M. et al. 2003. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum. 48:2555.
13. Shimizu, S., Nakashima, H., Masutani, K. et al. 2004. Antimonocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. Rheumatology (Oxford) 43:1121.
14. Inoue, A., Hasegawa, H., Kohno, M. et al. 2005. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum. 52:1522.
15. Chow, F. Y., Nikolic-Paterson, D. J., Ma, F. Y., Ozols, E., Rollins, B. J. and Tesch, G. H. 2007. Monocyte chemoattractant protein- 1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 50:471.
16. Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J. and Tesch, G. H. 2006. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 69:73.
17. Panzer, U., Steinmetz, O. M., Reinking, R. R. et al. 2006. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J. Am. Soc. Nephrol. 17:454.
18. Furuichi, K., Wada, T., Iwata, Y. et al. 2003. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 14:1066.
19. Furuichi, K., Wada, T., Iwata, Y. et al. 2003. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J. Am. Soc. Nephrol. 14:2503.
20. Miura, M., Fu, X., Zhang, Q. W., Remick, D. G. and Fairchild, R. L. 2001. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am. J. Pathol. 159:2137.
21. Oh, D. J., Dursun, B., He, Z. et al. 2008. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am. J. Physiol. Renal Physiol. 294:F264.
22. Fiorina, P., Ansari, M. J., Jurewicz, M. et al. 2006. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J. Am. Soc. Nephrol. 17:716.
23. Rozen, S. and Skaletsky, H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365.
24. Ramakers, C., Ruijter, J. M., Deprez, R. H. and Moorman, A. F. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339:62.
25. Bozic, C. R., Kolakowski, L. F. Jr, Gerard, N. P. et al. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:6048.
26. Lu, B., Rutledge, B. J., Gu, L. et al. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:601.
27. Rossi, D. and Zlotnik, A. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217.
28. Pulskens,W.P.,Teske,G.J.,Butter,L.M.et al. 2008. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3:e3596.
29. Roelofs, J. J., Rouschop, K. M., Leemans, J. C. et al. 2006. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J. Am. Soc. Nephrol. 17:131.
30. Leemans, J. C., Stokman, G., Claessen, N. et al. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115:2894.
31. Stokman, G., Leemans, J. C., Claessen, N., Weening, J. J. and Florquin, S. 2005. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J. Am. Soc. Nephrol. 16:1684.
32. Rouschop, K. M., Roelofs, J. J., Claessen, N. et al. 2005. Protection against renal ischemia reperfusion injury by CD44 disruption. J. Am. Soc. Nephrol. 16:2034.
33. Klausner, J. M., Paterson, I. S., Goldman, G. et al. 1989. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am. J. Physiol. 256:F794.
34. Bizzarri, C., Beccari, A. R., Bertini, R., Cavicchia, M. R., Giorgini, S. and Allegretti, M. 2006. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol. Ther. 112:139.
35. Safirstein, R., Megyesi, J., Saggi, S. J. et al. 1991. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am. J. Physiol. 261:F1095.
36. Reichel, C. A., Khandoga, A., Anders, H. J., Schlondorff, D., Luckow, B. and Krombach, F. 2006. Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue. J. Leukoc. Biol. 79:114.
37. Vinuesa, E., Hotter, G., Jung, M., Herrero-Fresneda, I., Torras, J. and Sola, A. 2008. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J. Pathol. 214:104.
38. Furuichi, K., Gao, J. L. and Murphy, P. M. 2006. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am. J. Pathol. 169:372.
39. Ricardo, S. D., van Goor, H. and Eddy, A. A. 2008. Macrophage diversity in renal injury and repair. J. Clin. Invest. 118:3522.
40. Huang, Y., Rabb, H. and Womer, K. L. 2007. Ischemia-reperfusion and immediate T cell responses. Cell. Immunol. 248:4.
41. Ascon, M., Ascon, D. B., Liu, M. et al. 2009. Renal ischemiareperfusion leads to long term infiltration of activated and effectormemory T lymphocytes. Kidney Int. 75:526.
42. Ueland, J. M., Gwira, J., Liu, Z. X. and Cantley, L. G. 2004. The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis. Am. J. Physiol. Renal Physiol. 286:F581.
43. Driscoll, K. E., Hassenbein, D. G., Howard, B. W. et al. 1995. Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J. Leukoc. Biol. 58:359.
44. Furuichi, K., Wada, T., Kitajikma, S. et al. 2008. IFN-inducible protein 10 (CXCL10) regulates tubular cell proliferation in renal ischemia-reperfusion injury. Nephron Exp. Nephrol. 109:c29.
45. Hogaboam, C. M., Bone-Larson, C. L., Steinhauser, M. L. et al. 1999. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. Faseb J. 13:1565.
46. Suzuki, H., Mori, M., Seto, K. et al. 2000. Rat CXC chemokine GRO/CINC-1 paradoxically stimulates the growth of gastric epithelial cells. Aliment Pharmacol. Ther. 14 (Suppl. 1):94.
47. Sasaki, S., Yoneyama, H., Suzuki, K. et al. 2002. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur. J. Immunol. 32:3197.
48. Viappiani, S., Sariahmetoglu, M. and Schulz, R. 2006. The role of matrix metalloproteinase inhibitors in ischemia-reperfusion injury in the liver. Curr. Pharm. Des. 12:2923.